Key terms

About VIRX

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VIRX news

Apr 18 12:28am ET Promising Clinical Trial Results Reinforce Buy Rating for Viracta Therapeutics by TipRanks Apr 17 7:50am ET Analysts Offer Insights on Healthcare Companies: Viracta Therapeutics (VIRX) and UnitedHealth (UNH) by TipRanks Apr 16 6:30am ET Analysts Offer Insights on Healthcare Companies: Icecure Medical (ICCM), Viracta Therapeutics (VIRX) and Bioxcel Therapeutics (BTAI) by TipRanks Apr 15 8:15am ET Viracta Therapeutics announces Nana-val results from stage 1 NAVAL-1 trial by TipRanks Mar 20 4:52pm ET Viracta Therapeutics CFO Resigns, Interim Successor Appointed by TipRanks Mar 12 6:28am ET Buy Rating for Viracta Therapeutics Backed by Upcoming Catalysts and Solid Financials by TipRanks Mar 11 12:50am ET Analysts Are Bullish on These Healthcare Stocks: iTeos Therapeutics (ITOS), Viracta Therapeutics (VIRX) by TipRanks Mar 08 7:27am ET RBC Capital Sticks to Its Buy Rating for Viracta Therapeutics (VIRX) by TipRanks Mar 07 4:41pm ET Viracta Therapeutics reports Q4 EPS (35c), consensus (31c) by TipRanks Feb 29 8:18am ET Viracta announces completion of second-stage enrollment in NAVAL-1 trial by TipRanks Feb 15 12:25pm ET Oppenheimer biotech/healthcare analysts hold analyst/industry conference call by TipRanks Feb 15 4:55am ET Oppenheimer biotech/healthcare analysts hold analyst/industry conference call by TipRanks Feb 13 5:12pm ET Oppenheimer biotech/healthcare analysts hold analyst/industry conference call by TipRanks

No recent press releases are available for VIRX

VIRX Financials

1-year income & revenue

Key terms

VIRX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VIRX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days